— Know what they know.
Not Investment Advice

AFFY OTC

Affymax, Inc.
1W: -20.0% 1M: +0.0% 3M: +23.1% YTD: +100.0% 1Y: +77.8% 3Y: -61.0% 5Y: -97.7%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Biotechnology · Tech Score Neutral · Power 52 · $59984 mcap · 37M float · 0.0085% daily turnover · Short 100% of daily vol

Cash Flow Trends

Operating Cash Flow
-$67M -81.1% ▼
Capital Expenditures
$0 +100.0% ▲
Free Cash Flow
-$67M -63.3% ▼
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 +0.0% ▲
Net Change in Cash
-$63M -550.0% ▼

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2009FY2010FY2011FY2012FY2013
— Operating Activities —
Net Income-$77M-$14M$0-$93M-$14M
Depreciation & Amort.$2M$2M$2M$2M$722K
Stock-Based Comp.$11M$12M$10M$11M$4M
Change in Working Capital-$18M-$50M-$23M-$3M-$20M
Other Non-Cash Items-$6K$652K-$61M$46M-$38M
Operating Cash Flow-$81M-$49M-$72M-$37M-$67M
— Investing Activities —
Capital Expenditures-$716K-$730K-$1M-$4M$0
Acquisitions (Net)$0$0$0$0$0
Investment Purchases-$29M-$129M-$36M-$13M$0
Investment Sales$79M$118M$45M$45M$13M
Other Investing$18K$2K$41K-$2M$1M
Investing Cash Flow$49M-$11M$8M$28M$14M
— Financing Activities —
Net Debt Issuance$9M-$9M$0$10M-$10M
Stock Repurchased-$1K$0$0$0$0
Dividends Paid$0$0$0$0$0
Other Financing$0$0$371K$12M$271K
Financing Cash Flow$133M-$1M$55M$23M-$10M
Net Change in Cash$101M-$62M-$9M$14M-$63M
Cash End of Period$125M$63M$54M$68M$6M
Free Cash Flow-$82M-$50M-$73M-$41M-$67M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms